Condition
Normal Non-fluency
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02554617CompletedPrimary
Measurements of Exhaled Nitric Oxide in Healthy Subjects in Thailand
NCT02447835Phase 1CompletedPrimary
Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
NCT01366781Not ApplicableCompletedPrimary
Gut Hormones After Meal Ingestion in Males Versus Females
NCT01729962CompletedPrimary
Comparative Study of the Optical Biometer for Measurements of the Eye
NCT01366768Not ApplicableCompletedPrimary
Gut Hormones After Oral Versus Intravenous Amino Acids
Showing all 5 trials